Preventing lung cancer by stopping smoking

Richard D. Hurt, Jon Owen Ebbert

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Much progress has been made in recent years in treating tobacco dependence. The 2000 USPHS Guideline extends the understanding of effective treatments and encourages clinicians to be more diligent in recognizing tobacco users in the practice and more aggressive in treating every tobacco user. The guideline outlines the potential use of the five first-line medications (bupropion, nicotine patches, gum, nasal spray, and inhaler) and the two second-line medications (nortriptyline and clonidine). The use of these medications can be tailored to meet the patients needs and combinations of these medications can be used when appropriate. More intensive treatment, such as residential treatment, may be needed for more addicted smokers.

Original languageEnglish (US)
Pages (from-to)27-36
Number of pages10
JournalClinics in Chest Medicine
Volume23
Issue number1
DOIs
StatePublished - 2002

Fingerprint

Tobacco
Lung Neoplasms
Smoking
Guidelines
Tobacco Use Cessation Products
Residential Treatment
Nortriptyline
Nasal Sprays
Bupropion
Tobacco Use Disorder
United States Public Health Service
Nebulizers and Vaporizers
Clonidine
Gingiva
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Preventing lung cancer by stopping smoking. / Hurt, Richard D.; Ebbert, Jon Owen.

In: Clinics in Chest Medicine, Vol. 23, No. 1, 2002, p. 27-36.

Research output: Contribution to journalArticle

Hurt, Richard D. ; Ebbert, Jon Owen. / Preventing lung cancer by stopping smoking. In: Clinics in Chest Medicine. 2002 ; Vol. 23, No. 1. pp. 27-36.
@article{f31ea38f3b6f43a7bf0a7e348ecea4b3,
title = "Preventing lung cancer by stopping smoking",
abstract = "Much progress has been made in recent years in treating tobacco dependence. The 2000 USPHS Guideline extends the understanding of effective treatments and encourages clinicians to be more diligent in recognizing tobacco users in the practice and more aggressive in treating every tobacco user. The guideline outlines the potential use of the five first-line medications (bupropion, nicotine patches, gum, nasal spray, and inhaler) and the two second-line medications (nortriptyline and clonidine). The use of these medications can be tailored to meet the patients needs and combinations of these medications can be used when appropriate. More intensive treatment, such as residential treatment, may be needed for more addicted smokers.",
author = "Hurt, {Richard D.} and Ebbert, {Jon Owen}",
year = "2002",
doi = "10.1016/S0272-5231(03)00074-1",
language = "English (US)",
volume = "23",
pages = "27--36",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Preventing lung cancer by stopping smoking

AU - Hurt, Richard D.

AU - Ebbert, Jon Owen

PY - 2002

Y1 - 2002

N2 - Much progress has been made in recent years in treating tobacco dependence. The 2000 USPHS Guideline extends the understanding of effective treatments and encourages clinicians to be more diligent in recognizing tobacco users in the practice and more aggressive in treating every tobacco user. The guideline outlines the potential use of the five first-line medications (bupropion, nicotine patches, gum, nasal spray, and inhaler) and the two second-line medications (nortriptyline and clonidine). The use of these medications can be tailored to meet the patients needs and combinations of these medications can be used when appropriate. More intensive treatment, such as residential treatment, may be needed for more addicted smokers.

AB - Much progress has been made in recent years in treating tobacco dependence. The 2000 USPHS Guideline extends the understanding of effective treatments and encourages clinicians to be more diligent in recognizing tobacco users in the practice and more aggressive in treating every tobacco user. The guideline outlines the potential use of the five first-line medications (bupropion, nicotine patches, gum, nasal spray, and inhaler) and the two second-line medications (nortriptyline and clonidine). The use of these medications can be tailored to meet the patients needs and combinations of these medications can be used when appropriate. More intensive treatment, such as residential treatment, may be needed for more addicted smokers.

UR - http://www.scopus.com/inward/record.url?scp=0036195582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036195582&partnerID=8YFLogxK

U2 - 10.1016/S0272-5231(03)00074-1

DO - 10.1016/S0272-5231(03)00074-1

M3 - Article

VL - 23

SP - 27

EP - 36

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

IS - 1

ER -